Altered O-glycan synthesis in lymphocytes from patients with Wiskott- Aldrich syndrome

doi:10.1084/jem.173.6.1501

This Article

	Full Text (PDF, 1191K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Piller, F.
	Articles by Fukuda, M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Piller, F.
	Articles by Fukuda, M.


Social Bookmarking

	What's this?

ARTICLES

Altered O-glycan synthesis in lymphocytes from patients with Wiskott- Aldrich syndrome

F Piller, F Le Deist, KI Weinberg, R Parkman and M Fukuda
La Jolla Cancer Research Foundation, California 92037.

The only molecular defect reported for the X-linked immunodeficiency Wiskott-Aldrich syndrome (WAS) is the abnormal electrophoretic behavior of the major T lymphocyte sialoglycoprotein CD43. Since the 70 to 80 O- linked carbohydrate chains of CD43 are known to influence markedly its electrophoretic mobility, we analyzed the structure and the biosynthesis of O-glycans of CD43 in lymphocytes from patients with WAS. Immunofluorescence analysis with the carbohydrate dependent anti- CD43 antibody T305 revealed that in 10 out of the 12 WAS patients tested increased numbers of T lymphocytes carry on CD43 an epitope which on normal lymphocytes is expressed only after activation. Other activation antigens were absent from WAS lymphocytes. Western blots of WAS cell lysates displayed a high molecular mass form of CD43 which reacted with the T305 antibody and which could be found on in vivo activated lymphocytes but was absent from normal unstimulated lymphocytes. To examine the O-glycan structures, carbohydrate labeled CD43 was immunoprecipitated and the released oligosaccharides identified. WAS lymphocyte CD43 was found to carry predominantly the branched structure NeuNAc alpha 2----3Gal beta 1----3 (NeuNAc alpha 2--- -3Gal beta 1----4G1cNAc beta 1----6) GalNAcOH whereas normal lymphocytes carry the structure NeuNAc alpha 2----3Gal beta 1----3 (NeuNAc alpha 2----6) GalNAcOH. Only after activation NeuNAc alpha 2---- 3Gal beta 1----3 (NeuNAc alpha 2----3Gal beta 1----4GlcNAc beta 1----6) GalNAcOH becomes the principal oligosaccharide on CD43 from normal lymphocytes. Analyzing the six glycosyltransferases involved in the biosynthesis of these O-glycan structures it was found that in WAS lymphocytes high levels of beta 1----6 N-acetyl-glucosaminyl transferase are responsible for the expression of NeuNAc alpha 2---- 3Gal beta 1----3 (NeuNAc alpha 2----3Gal beta 1----4GlcNAc beta 1----6) GalNAcOH on CD43. The gene responsible for WAS has not yet been identified but the results presented in this study suggest that the primary defect in WAS may affect a gene which is involved in the regulation of O-glycosylation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Mody, P. D., Cannon, J. L., Bandukwala, H. S., Blaine, K. M., Schilling, A. B., Swier, K., Sperling, A. I. (2007). Signaling through CD43 regulates CD4 T-cell trafficking. Blood 110: 2974-2982 [Abstract] [Full Text]
Fuhlbrigge, R. C., King, S. L., Sackstein, R., Kupper, T. S. (2006). CD43 is a ligand for E-selectin on CLA+ human T cells. Blood 107: 1421-1426 [Abstract] [Full Text]
Hagisawa, S., Ohyama, C., Takahashi, T., Endoh, M., Moriya, T., Nakayama, J., Arai, Y., Fukuda, M. (2005). Expression of core 2 {beta}1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. Glycobiology 15: 1016-1024 [Abstract] [Full Text]
Fernandez-Cabezudo, M. J., Vijayasarathy, C., Pflugh, D. L., Bothwell, A. L. M., al-Ramadi, B. K. (2004). Evidence for a dual pathway of activation in CD43-stimulated Th2 cells: differential requirement for the Lck tyrosine kinase. Int Immunol 16: 1215-1223 [Abstract] [Full Text]
Kyoizumi, S., Ohara, T., Kusunoki, Y., Hayashi, T., Koyama, K., Tsuyama, N. (2004). Expression Characteristics and Stimulatory Functions of CD43 in Human CD4+ Memory T Cells: Analysis Using a Monoclonal Antibody to CD43 That Has a Novel Lineage Specificity. J. Immunol. 172: 7246-7253 [Abstract] [Full Text]
Markine-Goriaynoff, N., Gillet, L., Karlsen, O. A., Haarr, L., Minner, F., Pastoret, P.-P., Fukuda, M., Vanderplasschen, A. (2004). The core 2 {beta}-1,6-N-acetylglucosaminyltransferase-M encoded by bovine herpesvirus 4 is not essential for virus replication despite contributing to post-translational modifications of structural proteins. J. Gen. Virol. 85: 355-367 [Abstract] [Full Text]
Lanteri, M., Giordanengo, V., Hiraoka, N., Fuzibet, J.-G., Auberger, P., Fukuda, M., Baum, L. G., Lefebvre, J.-C. (2003). Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. Glycobiology 13: 909-918 [Abstract] [Full Text]
El-Battari, A., Prorok, M., Angata, K., Mathieu, S., Zerfaoui, M., Ong, E., Suzuki, M., Lombardo, D., Fukuda, M. (2003). Different glycosyltransferases are differentially processed for secretion, dimerization, and autoglycosylation. Glycobiology 13: 941-953 [Abstract] [Full Text]
Mitoma, J., Petryniak, B., Hiraoka, N., Yeh, J.-C., Lowe, J. B., Fukuda, M. (2003). Extended Core 1 and Core 2 Branched O-Glycans Differentially Modulate Sialyl Lewis x-type L-selectin Ligand Activity. J. Biol. Chem. 278: 9953-9961 [Abstract] [Full Text]
Dimitroff, C. J., Bernacki, R. J., Sackstein, R. (2003). Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin. Blood 101: 602-610 [Abstract] [Full Text]
Nguyen, J. T., Evans, D. P., Galvan, M., Pace, K. E., Leitenberg, D., Bui, T. N., Baum, L. G. (2001). CD45 Modulates Galectin-1-Induced T Cell Death: Regulation by Expression of Core 2 O-Glycans. J. Immunol. 167: 5697-5707 [Abstract] [Full Text]
Fukuoka, M., Fukudome, K., Yamashita, Y., Tokushima, M., Miyake, K., Kimoto, M. (2000). Antiadhesive function of 130-kd glycoform of CD43 expressed in CD4 T-lymphocyte clones and transfectant cell lines. Blood 96: 4267-4275 [Abstract] [Full Text]
Durand, G., Seta, N. (2000). Protein Glycosylation and Diseases: Blood and Urinary Oligosaccharides as Markers for Diagnosis and Therapeutic Monitoring. Clin. Chem. 46: 795-805 [Abstract] [Full Text]
Fabbi, M., Geginat, J., Tiso, M., Ramarli, D., Parent, D., Bargellesi, A., Remold-O'Donnell, E. (1999). 8B4/20, A Private CD43 Epitope on Developing Human Thymocytes, Is Involved in Thymocyte Maturation. J. Immunol. 163: 5964-5970 [Abstract] [Full Text]
Zhang, J., Shehabeldin, A., da Cruz, L. A.G., Butler, J., Somani, A.-K., McGavin, M., Kozieradzki, I., dos Santos, A. O., Nagy, A., Grinstein, S., Penninger, J. M., Siminovitch, K. A. (1999). Antigen Receptor-induced Activation and Cytoskeletal Rearrangement Are Impaired in Wiskott-Aldrich Syndrome Protein-deficient Lymphocytes. JEM 190: 1329-1342 [Abstract] [Full Text]
Mukasa, R., Homma, T., Ohtsuki, T., Hosono, O., Souta, A., Kitamura, T., Fukuda, M., Watanabe, S., Morimoto, C. (1999). Core 2-containing O-glycans on CD43 are preferentially expressed in the memory subset of human CD4 T cells. Int Immunol 11: 259-268 [Abstract] [Full Text]
Ujita, M., McAuliffe, J., Schwientek, T., Almeida, R., Hindsgaul, O., Clausen, H., Fukuda, M. (1998). Synthesis of Poly-N-acetyllactosamine in Core 2�Branched O-Glycans. THE REQUIREMENT OF NOVEL beta -1,4-GALACTOSYLTRANSFERASE IV AND beta -1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE. J. Biol. Chem. 273: 34843-34849 [Abstract] [Full Text]
Tsuboi, S., Fukuda, M. (1998). Overexpression of Branched O-Linked Oligosaccharides on T Cell Surface Glycoproteins Impairs Humoral Immune Responses in Transgenic Mice. J. Biol. Chem. 273: 30680-30687 [Abstract] [Full Text]
Sakkas, L. I., Scanzello, C., Johanson, N., Burkholder, J., Mitra, A., Salgame, P., Katsetos, C. D., Platsoucas, C. D. (1998). T Cells and T-Cell Cytokine Transcripts in the Synovial Membrane in Patients with Osteoarthritis. CVI 5: 430-437 [Abstract] [Full Text]
Li, C.-M., Adler, K. B., Cheng, P.-W. (1998). Mucin Biosynthesis: Molecular Cloning and Expression of Bovine Lung Mucin Core 2�N-Acetylglucosaminyltransferase cDNA. Am. J. Respir. Cell Mol. Bio. 18: 343-352 [Abstract] [Full Text]
Skrincosky, D., Kain, R., El-Battari, A., Exner, M., Kerjaschki, D., Fukuda, M. (1997). Altered Golgi Localization of Core 2�beta -1,6-N-Acetylglucosaminyltransferase Leads to Decreased Synthesis of Branched O-Glycans. J. Biol. Chem. 272: 22695-22702 [Abstract] [Full Text]
Parolini, O., Berardelli, S., Riedl, E., Bello-Fernandez, C., Strobl, H., Majdic, O., Knapp, W. (1997). Expression of Wiskott-Aldrich Syndrome Protein (WASP) Gene During Hematopoietic Differentiation. Blood 90: 70-75 [Abstract] [Full Text]
Pedraza-Alva, G., Merida, L. B., Burakoff, S. J., Rosenstein, Y. (1996). CD43-specific Activation of T Cells Induces Association of CD43 to Fyn Kinase. J. Biol. Chem. 271: 27564-27568 [Abstract] [Full Text]
Bierhuizen, M F, Mattei, M G, Fukuda, M (1993). Expression of the developmental I antigen by a cloned human cDNA encoding a member of a beta-1,6-N-acetylglucosaminyltransferase gene family.. Genes Dev. 7: 468-478 [Abstract]
Galvan, M., Tsuboi, S., Fukuda, M., Baum, L. G. (2000). Expression of a Specific Glycosyltransferase Enzyme Regulates T Cell Death Mediated by Galectin-1. J. Biol. Chem. 275: 16730-16737 [Abstract] [Full Text]
Vanderplasschen, A., Markine-Goriaynoff, N., Lomonte, P., Suzuki, M., Hiraoka, N., Yeh, J.-C., Bureau, F., Willems, L., Thiry, E., Fukuda, M., Pastoret, P.-P. (2000). A multipotential beta -1,6-N-acetylglucosaminyl-transferase is encoded by bovine herpesvirus type 4. Proc. Natl. Acad. Sci. USA 97: 5756-5761 [Abstract] [Full Text]